Journal
MOLECULAR DIAGNOSIS & THERAPY
Volume 17, Issue 2, Pages 71-84Publisher
ADIS INT LTD
DOI: 10.1007/s40291-013-0023-x
Keywords
-
Categories
Funding
- National Cancer Institute [RO1 CA116161]
- Florida Department of Health James and Esther King Biomedical Program [10KT-01, IKF06]
Ask authors/readers for more resources
Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available